- AUM91F ;IHS/SD/DMJ,SDR,GTH - ICD 9 CODES FOR FY 2009 ; [ 08/18/2003 4:01 PM ]
- ;;10.2;TABLE MAINTENANCE;;MAR 09, 2010
- ;
- ICD9NEW3 ;
- ;;611.81^Ptosis of breast^Ptosis of breast^^9^600,601
- ;;611.82^Hypoplasia of breast^Hypoplasia of breast^^9^600,601
- ;;611.83^Capsular cntractre breast impl^Capsular contracture of breast implant^^9^600,601
- ;;611.89^Oth spec disorders of breast^Other specified disorders of breast^^9^600,601
- ;;612.0^Deformity of recnstruct breast^Deformity of reconstructed breast^^9^600,601
- ;;612.1^Disprop of reconstrcted breast^Disproportion of reconstructed breast^^9^600,601
- ;;625.70^Vulvodynia, unspecified^Vulvodynia, unspecified^F^13^742,743,760,761
- ;;625.71^Vulvar vestibulitis^Vulvar vestibulitis^F^13^742,743,757,758,759
- ;;625.79^Other vulvodynia^Other vulvodynia^F^13^742,743,760,761
- ;;649.70^Cerv shortng unspec care or NA^Cervical shortening, unspecified as to episode of care or not applicable^F^14^998
- ;;649.71^Cerv shtng del w/w/o antep cnd^Cervical shortening, delivered, with or without mention of antepartum condition^F^14^765,766,767,768,774,775
- ;;649.73^Cerv shrtng antepar cond or cc^Cervical shortening, antepartum condition or complication^F^14^781,782
- ;;678.00^Fetl hema cnds unsp care or NA^Fetal hematologic conditions, unspecified as to episode of care or not applicable^F^14^998
- ;;678.01^Fetl hema cnds del w/w/o antep^Fetal hematologic conditions, delivered, with or without mention of antepartum condition^F^14^765,766,767,768,774,775
- ;;678.03^Fetal hemat cndtns antep cond^Fetal hematologic conditions, antepartum condition or complication^F^14^781,782
- ;;678.10^Fetl conj twns unsp care or NA^Fetal conjoined twins, unspecified as to episode of care or not applicable^F^14^998
- ;;678.11^Fetl conj twns del w/w/o antep^Fetal conjoined twins, delivered, with or without mention of antepartum condition^F^14^765,766,767,768,774,775
- ;;678.13^Fetl conjnd twns antep cond cc^Fetal conjoined twins, antepartum condition or complication^F^14^781,782
- ;;679.00^Mat cc in utero unspec care/NA^Maternal complications from in utero procedure, unspecified as to episode of care or not applicable^F^14^765,766,767,768,774,775
- ;;679.01^Mat cc in utro del w/w/o antep^Maternal complications from in utero procedure, delivered, with or without mention of antepartum condition^F^14^765,766,767,768,774
- ;;679.02^Mat cc in utro prc del w/pp cc^Maternal complications from in utero procedure, delivered, with mention of postpartum complication^F^14^765,766,767,768,774
- ;;679.03^Mat cc in utero proc antepart^Maternal complications from in utero procedure, antepartum condition or complication^F^14^781,782
- ;;679.04^Mat cc in utero proc postpart^Maternal complications from in utero procedure, postpartum condition or complication^F^14^769,776
- ;;679.10^Fetl cc in utr prc unsp careNA^Fetal complications from in utero procedures, unspecified as to episode of care or not applicable^F^14^998
- ;;679.11^Fetl cc in utro del w/w/o antp^Fetal complications from in utero procedures, delivered, with or without mention of antepartum condition^F^14^765,766,767,768,774,775
- ;;679.12^Fetl cc utro prc del w/pp cc^Fetal complications from in utero procedures, delivered, with mention of postpartum complication^F^14^765,766,767,768,774,775
- ;;679.13^Fetl cc in utro prc antep cond^Fetal complications from in utero procedures, antepartum condition or complication^F^14^781,782
- ;;679.14^Fetl cc in utr proc postp cond^Fetal complications from in utero procedures, postpartum condition or complication^F^14^769,776
- ;;695.10^Erythema multiforme, unspec^Erythema multiforme, unspecified^^9^595,596
- ;;695.11^Erythema multiforme minor^Erythema multiforme minor^^9^595,596
- ;;695.12^Erythema multiforme major^Erythema multiforme major^^9^595,596
- ;;695.13^Stevens-Johnson syndrome^Stevens-Johnson syndrome^^9^595,596
- ;;695.14^Stev-Johns synd toxic epi necr^Stevens-Johnson syndrome-toxic epidermal necrolysis overlap syndrome^^9^595,596
- ;;695.15^Toxic epidermal necrolysis^Toxic epidermal necrolysis^^9^595,596
- ;;695.19^Other erythema multiforme^Other erythema multiforme^^9^595,596
- ;;695.50^Exfol eryth inv <10 body surf^Exfoliation due to erythematous condition involving less than 10 percent of body surface^^9^606,607
- ;;695.51^Exfol eryth inv 10-19 body sur^Exfoliation due to erythematous condition involving 10-19 percent of body surface^^9^606,607
- ;;695.52^Exfol eryth inv 20-29 body sur^Exfoliation due to erythematous condition involving 20-29 percent of body surface^^9^606,607
- ;;695.53^Exfol eryth inv 30-39 body sur^Exfoliation due to erythematous condition involving 30-39 percent of body surface^^9^606,607
- ;;695.54^Exfol eryth inv 40-49 body sur^Exfoliation due to erythematous condition involving 40-49 percent of body surface^^9^606,607
- ;;695.55^Exfol eryth inv 50-59 body sur^Exfoliation due to erythematous condition involving 50-59 percent of body surface^^9^606,607
- ;;695.56^Exfol eryth inv 60-69 body sur^Exfoliation due to erythematous condition involving 60-69 percent of body surface^^9^606,607
- ;;695.57^Exfol eryth inv 70-79 body sur^Exfoliation due to erythematous condition involving 70-79 percent of body surface^^9^606,607
- ;;695.58^Exfol eryth inv 80-89 body sur^Exfoliation due to erythematous condition involving 80-89 percent of body surface^^9^606,607
- ;;695.59^Exfol eryth inv > 90% body sur^Exfoliation due to erythematous condition involving 90 percent or more of body surface^^9^606,607
- ;;707.20^Pressure ulcer, unspec stage^Pressure ulcer, unspecified stage^^9^573,574,575,592,593,594
- ;;707.21^Pressure ulcer, stage I^Pressure ulcer, stage I^^9^573,574,575,592,593,594
- ;;707.22^Pressure ulcer, stage II^Pressure ulcer, stage II^^9^573,574,575,592,593,594
- ;;707.23^Pressure ulcer, stage III^Pressure ulcer, stage III^^9^573,574,575,592,593,594
- ;;707.24^Pressure ulcer, stage IV^Pressure ulcer, stage IV^^9^573,574,575,592,593,594
- ;;707.25^Pressure ulcer, unstageable^Pressure ulcer, unstageable
- ;;729.90^Disorders soft tissue, unspec^Disorders of soft tissue, unspecified^^8^555,556
- ;;729.91^Post-traumatic seroma^Post-traumatic seroma^^8^555,556
- ;;729.92^Nontrauma hematoma soft tissue^Nontraumatic hematoma of soft tissue^^8^555,556
- ;;729.99^Other disorders of soft tissue^Other disorders of soft tissue^^8^555,556
- ;;733.96^Stress fracture-femoral neck^Stress Fracture of femoral neck
- ;;733.97^Stress fracture-shaft of femur^Stress fracture of shaft of femur
- ;;733.98^Stress fracture-pelvis^Stress fracture of pelvis
- ;;760.61^Newbn affcted by amniocentesis^Newborn affected by amniocentesis^^15^794
- ;;760.62^NB affct by oth in utero proce^Newborn affected by other in utero procedure^^15^794
- ;;760.63^NB aff oth surg op on moth prg^Newborn affected by other surgical operations on mother during pregnancy^^15^794
- ;;760.64^NB aff surg, mo not asoc w/prg^Newborn affected by previous surgical procedure on mother not associated with pregnancy^^15^794
- ;;777.50^Necrotzng entercolitis NB Unsp^Necrotizing enterocolitis in newborn, unspecified^^15^791,793
- ;;777.51^Stg I necro entercolitis in NB^Stage I necrotizing enterocolitis in newborn^^15^791,793
- ;;777.52^Stg II necro enterclitis in NB^Stage II necrotizing enterocolitis in newborn^^15^791,793
- ;;777.53^Stg III necro entrclitis in NB^Stage III necrotizing enterocolitis in newborn^^15^791,793
- ;;780.60^Fever, unspecified^Fever, unspecified
- ;;780.61^Fever w conditn class elswhre^Fever presenting with conditions classified elsewhere
- ;;780.62^Postprocedural fever^Postprocedural fever
- ;;780.63^Postvaccination fever^Postvaccination fever
- ;;780.64^Chills (without fever)^Chills (without fever)
- ;;780.65^Hypotherm not assoc w low temp^Hypothermia not associated with low environmental tempurature
- ;;780.72^Functional quadriplegia^Functional quadriplegia^^1^52,53
- ;;788.91^Functionl urinary incontinence^Functional urinary incontinence^^11^695,696
- ;;788.99^Oth symptoms inv urinary syst^Other symptoms involving urinary system^^11^695,696
- ;;795.07^Sat cerv smr lackg transf zone^Satisfactory cervical smear but lacking transformation zone^F^13^742,743,760,761
- ;;795.10^Abn glandr Pap smear vagina^Abnormal glandular Papanicolaou smear of vagina^F^13^742,743,760,761
- ;;795.11^Pap smr vagina with ASC-US^Papanicolaou smear of vagina with atypical squamous cells of undetermined significance (ASC-US)^F^13^742,743,760,761
- ;;795.12^Pap smr vagina with ASC-H^Papanicolaou smear of vagina with atypical squamous cells cannot exclude high grade squamous intraepithelial lesion (ASC-H)^F^13^742,743,760,761
- ;;795.13^Pap smr vagina with LGSIL^Papanicolaou smear of vagina with low grade squamous intraepithelial lesion (LGSIL)^F^13^742,743,760,761
- ;;795.14^Pap smr vagina with HGSIL^Papanicolaou smear of vagina with high grade squamous intraepithelial lesion (HGSIL)^F^13^742,743,760,761
- ;;795.15^Vag high rsk HPV DNA test pos^Vaginal high risk human papillomavirus (HPV) DNA test positive^F^13^742,743,760,761
- ;;795.16^Pap smr vag w/cyto evid malign^Papanicolaou smear of vagina with cytologic evidence of malignancy^F^13^742,743,760,761
- ;;795.18^Unsat vaginal cytology smear^Unsatisfactory vaginal cytology smear^F^13^742,743,760,761
- ;;795.19^Oth abn Pap smr vag/vagnal HPV^Other abnormal Papanicolaou smear of vagina and vaginal HPV^F^13^742,743,760,761
- ;;796.70^Abnr glandular Pap smear anus^Abnormal glandular Papanicolaou smear of anus^^6^393,394,395
- ;;796.71^Pap smr anus with ASC-US^Papanicolaou smear of anus with atypical squamous cells of undetermined significance (ASC-US)^^6^393,394,395
- ;;796.72^Pap smr anus w/atypcl sq cells^Papanicolaou smear of anus with atypical squamous cells cannot exclude high grade squamous intraepithelial lesion (ASC-H)^^6^393,394,395
- ;;796.73^Pap smr anus with LGSIL^Papanicolaou smear of anus with low grade squamous intraepithelial lesion (LGSIL)^^6^393,394,395
- ;;796.74^Pap smear anus with HGSIL^Papanicolaou smear of anus with high grade squamous intraepithelial lesion (HGSIL)^^6^393,394,395
- ;;796.75^Anal high rsk HPV DNA test pos^Anal high risk human papillomavirus (HPV) DNA test positive^^6^393,394,395
- ;;796.76^Pap smr anus w/cyto evd malign^Papanicolaou smear of anus with cytologic evidence of malignancy^^6^393,394,395
- ;;796.77^Satsf anal smr lckng trnfor zn^Satisfactory anal smear but lacking transformation zone^^6^393,394,395
- ;;796.78^Unsatsfactry anal cytolgy smr^Unsatisfactory anal cytology smear^^6^393,394,395
- ;;796.79^Oth abno Pap smr anus/anal HPV^Other abnormal Papanicolaou smear of anus and anal HPV^^6^393,394,395
- ;;997.31^Ventilator assoc pneumonia^Ventilator associated pneumonia^^4^205,206
- ;;997.39^Oth respiratory complications^Other respiratory complications^^4^205,206
- ;;998.30^Disruption of wound,unspecif^Disruption of wound, unspecified^^21^919,920,921
- ;;998.33^Disruptn traumatc wound repair^Disruption of traumatic wound repair^^21^919,920,921
- ;;999.81^Extravas of vesicant chemother^Extravasation of vesicant chemotherapy^^5^314,315,316
- ;;999.82^Estravas of Oth vesicant agent^Extravasation of other vesicant agent^^5^314,315,316
- ;;999.88^Other infusion reaction^Other infusion reaction^^5^314,315,316
- ;;999.89^Other transfusion reaction^Other transfusion reaction^^15^791,793
- ;;END
- PRNT ;
- S U="^"
- W !," CODE",?10,"DIAGNOSIS",!?10,"DESCRIPTION",!," -----",?10,"-----------"
- NEW X,Y,P2,P3
- F X=1:1 S Y=$P($T(ICD9NEW+X),";;",3),P2=$P(Y,U,2),P3=$P(Y,U,3) Q:Y="END" W !," ",$P(Y,U,1),?10,$S($L(P3):P3,1:P2),!?10,P2
- Q
- AUM91F ;IHS/SD/DMJ,SDR,GTH - ICD 9 CODES FOR FY 2009 ; [ 08/18/2003 4:01 PM ]
- +1 ;;10.2;TABLE MAINTENANCE;;MAR 09, 2010
- +2 ;
- ICD9NEW3 ;
- +1 ;;611.81^Ptosis of breast^Ptosis of breast^^9^600,601
- +2 ;;611.82^Hypoplasia of breast^Hypoplasia of breast^^9^600,601
- +3 ;;611.83^Capsular cntractre breast impl^Capsular contracture of breast implant^^9^600,601
- +4 ;;611.89^Oth spec disorders of breast^Other specified disorders of breast^^9^600,601
- +5 ;;612.0^Deformity of recnstruct breast^Deformity of reconstructed breast^^9^600,601
- +6 ;;612.1^Disprop of reconstrcted breast^Disproportion of reconstructed breast^^9^600,601
- +7 ;;625.70^Vulvodynia, unspecified^Vulvodynia, unspecified^F^13^742,743,760,761
- +8 ;;625.71^Vulvar vestibulitis^Vulvar vestibulitis^F^13^742,743,757,758,759
- +9 ;;625.79^Other vulvodynia^Other vulvodynia^F^13^742,743,760,761
- +10 ;;649.70^Cerv shortng unspec care or NA^Cervical shortening, unspecified as to episode of care or not applicable^F^14^998
- +11 ;;649.71^Cerv shtng del w/w/o antep cnd^Cervical shortening, delivered, with or without mention of antepartum condition^F^14^765,766,767,768,774,775
- +12 ;;649.73^Cerv shrtng antepar cond or cc^Cervical shortening, antepartum condition or complication^F^14^781,782
- +13 ;;678.00^Fetl hema cnds unsp care or NA^Fetal hematologic conditions, unspecified as to episode of care or not applicable^F^14^998
- +14 ;;678.01^Fetl hema cnds del w/w/o antep^Fetal hematologic conditions, delivered, with or without mention of antepartum condition^F^14^765,766,767,768,774,775
- +15 ;;678.03^Fetal hemat cndtns antep cond^Fetal hematologic conditions, antepartum condition or complication^F^14^781,782
- +16 ;;678.10^Fetl conj twns unsp care or NA^Fetal conjoined twins, unspecified as to episode of care or not applicable^F^14^998
- +17 ;;678.11^Fetl conj twns del w/w/o antep^Fetal conjoined twins, delivered, with or without mention of antepartum condition^F^14^765,766,767,768,774,775
- +18 ;;678.13^Fetl conjnd twns antep cond cc^Fetal conjoined twins, antepartum condition or complication^F^14^781,782
- +19 ;;679.00^Mat cc in utero unspec care/NA^Maternal complications from in utero procedure, unspecified as to episode of care or not applicable^F^14^765,766,767,768,774,775
- +20 ;;679.01^Mat cc in utro del w/w/o antep^Maternal complications from in utero procedure, delivered, with or without mention of antepartum condition^F^14^765,766,767,768,774
- +21 ;;679.02^Mat cc in utro prc del w/pp cc^Maternal complications from in utero procedure, delivered, with mention of postpartum complication^F^14^765,766,767,768,774
- +22 ;;679.03^Mat cc in utero proc antepart^Maternal complications from in utero procedure, antepartum condition or complication^F^14^781,782
- +23 ;;679.04^Mat cc in utero proc postpart^Maternal complications from in utero procedure, postpartum condition or complication^F^14^769,776
- +24 ;;679.10^Fetl cc in utr prc unsp careNA^Fetal complications from in utero procedures, unspecified as to episode of care or not applicable^F^14^998
- +25 ;;679.11^Fetl cc in utro del w/w/o antp^Fetal complications from in utero procedures, delivered, with or without mention of antepartum condition^F^14^765,766,767,768,774,775
- +26 ;;679.12^Fetl cc utro prc del w/pp cc^Fetal complications from in utero procedures, delivered, with mention of postpartum complication^F^14^765,766,767,768,774,775
- +27 ;;679.13^Fetl cc in utro prc antep cond^Fetal complications from in utero procedures, antepartum condition or complication^F^14^781,782
- +28 ;;679.14^Fetl cc in utr proc postp cond^Fetal complications from in utero procedures, postpartum condition or complication^F^14^769,776
- +29 ;;695.10^Erythema multiforme, unspec^Erythema multiforme, unspecified^^9^595,596
- +30 ;;695.11^Erythema multiforme minor^Erythema multiforme minor^^9^595,596
- +31 ;;695.12^Erythema multiforme major^Erythema multiforme major^^9^595,596
- +32 ;;695.13^Stevens-Johnson syndrome^Stevens-Johnson syndrome^^9^595,596
- +33 ;;695.14^Stev-Johns synd toxic epi necr^Stevens-Johnson syndrome-toxic epidermal necrolysis overlap syndrome^^9^595,596
- +34 ;;695.15^Toxic epidermal necrolysis^Toxic epidermal necrolysis^^9^595,596
- +35 ;;695.19^Other erythema multiforme^Other erythema multiforme^^9^595,596
- +36 ;;695.50^Exfol eryth inv <10 body surf^Exfoliation due to erythematous condition involving less than 10 percent of body surface^^9^606,607
- +37 ;;695.51^Exfol eryth inv 10-19 body sur^Exfoliation due to erythematous condition involving 10-19 percent of body surface^^9^606,607
- +38 ;;695.52^Exfol eryth inv 20-29 body sur^Exfoliation due to erythematous condition involving 20-29 percent of body surface^^9^606,607
- +39 ;;695.53^Exfol eryth inv 30-39 body sur^Exfoliation due to erythematous condition involving 30-39 percent of body surface^^9^606,607
- +40 ;;695.54^Exfol eryth inv 40-49 body sur^Exfoliation due to erythematous condition involving 40-49 percent of body surface^^9^606,607
- +41 ;;695.55^Exfol eryth inv 50-59 body sur^Exfoliation due to erythematous condition involving 50-59 percent of body surface^^9^606,607
- +42 ;;695.56^Exfol eryth inv 60-69 body sur^Exfoliation due to erythematous condition involving 60-69 percent of body surface^^9^606,607
- +43 ;;695.57^Exfol eryth inv 70-79 body sur^Exfoliation due to erythematous condition involving 70-79 percent of body surface^^9^606,607
- +44 ;;695.58^Exfol eryth inv 80-89 body sur^Exfoliation due to erythematous condition involving 80-89 percent of body surface^^9^606,607
- +45 ;;695.59^Exfol eryth inv > 90% body sur^Exfoliation due to erythematous condition involving 90 percent or more of body surface^^9^606,607
- +46 ;;707.20^Pressure ulcer, unspec stage^Pressure ulcer, unspecified stage^^9^573,574,575,592,593,594
- +47 ;;707.21^Pressure ulcer, stage I^Pressure ulcer, stage I^^9^573,574,575,592,593,594
- +48 ;;707.22^Pressure ulcer, stage II^Pressure ulcer, stage II^^9^573,574,575,592,593,594
- +49 ;;707.23^Pressure ulcer, stage III^Pressure ulcer, stage III^^9^573,574,575,592,593,594
- +50 ;;707.24^Pressure ulcer, stage IV^Pressure ulcer, stage IV^^9^573,574,575,592,593,594
- +51 ;;707.25^Pressure ulcer, unstageable^Pressure ulcer, unstageable
- +52 ;;729.90^Disorders soft tissue, unspec^Disorders of soft tissue, unspecified^^8^555,556
- +53 ;;729.91^Post-traumatic seroma^Post-traumatic seroma^^8^555,556
- +54 ;;729.92^Nontrauma hematoma soft tissue^Nontraumatic hematoma of soft tissue^^8^555,556
- +55 ;;729.99^Other disorders of soft tissue^Other disorders of soft tissue^^8^555,556
- +56 ;;733.96^Stress fracture-femoral neck^Stress Fracture of femoral neck
- +57 ;;733.97^Stress fracture-shaft of femur^Stress fracture of shaft of femur
- +58 ;;733.98^Stress fracture-pelvis^Stress fracture of pelvis
- +59 ;;760.61^Newbn affcted by amniocentesis^Newborn affected by amniocentesis^^15^794
- +60 ;;760.62^NB affct by oth in utero proce^Newborn affected by other in utero procedure^^15^794
- +61 ;;760.63^NB aff oth surg op on moth prg^Newborn affected by other surgical operations on mother during pregnancy^^15^794
- +62 ;;760.64^NB aff surg, mo not asoc w/prg^Newborn affected by previous surgical procedure on mother not associated with pregnancy^^15^794
- +63 ;;777.50^Necrotzng entercolitis NB Unsp^Necrotizing enterocolitis in newborn, unspecified^^15^791,793
- +64 ;;777.51^Stg I necro entercolitis in NB^Stage I necrotizing enterocolitis in newborn^^15^791,793
- +65 ;;777.52^Stg II necro enterclitis in NB^Stage II necrotizing enterocolitis in newborn^^15^791,793
- +66 ;;777.53^Stg III necro entrclitis in NB^Stage III necrotizing enterocolitis in newborn^^15^791,793
- +67 ;;780.60^Fever, unspecified^Fever, unspecified
- +68 ;;780.61^Fever w conditn class elswhre^Fever presenting with conditions classified elsewhere
- +69 ;;780.62^Postprocedural fever^Postprocedural fever
- +70 ;;780.63^Postvaccination fever^Postvaccination fever
- +71 ;;780.64^Chills (without fever)^Chills (without fever)
- +72 ;;780.65^Hypotherm not assoc w low temp^Hypothermia not associated with low environmental tempurature
- +73 ;;780.72^Functional quadriplegia^Functional quadriplegia^^1^52,53
- +74 ;;788.91^Functionl urinary incontinence^Functional urinary incontinence^^11^695,696
- +75 ;;788.99^Oth symptoms inv urinary syst^Other symptoms involving urinary system^^11^695,696
- +76 ;;795.07^Sat cerv smr lackg transf zone^Satisfactory cervical smear but lacking transformation zone^F^13^742,743,760,761
- +77 ;;795.10^Abn glandr Pap smear vagina^Abnormal glandular Papanicolaou smear of vagina^F^13^742,743,760,761
- +78 ;;795.11^Pap smr vagina with ASC-US^Papanicolaou smear of vagina with atypical squamous cells of undetermined significance (ASC-US)^F^13^742,743,760,761
- +79 ;;795.12^Pap smr vagina with ASC-H^Papanicolaou smear of vagina with atypical squamous cells cannot exclude high grade squamous intraepithelial lesion (ASC-H)^F^13^742,743,760,761
- +80 ;;795.13^Pap smr vagina with LGSIL^Papanicolaou smear of vagina with low grade squamous intraepithelial lesion (LGSIL)^F^13^742,743,760,761
- +81 ;;795.14^Pap smr vagina with HGSIL^Papanicolaou smear of vagina with high grade squamous intraepithelial lesion (HGSIL)^F^13^742,743,760,761
- +82 ;;795.15^Vag high rsk HPV DNA test pos^Vaginal high risk human papillomavirus (HPV) DNA test positive^F^13^742,743,760,761
- +83 ;;795.16^Pap smr vag w/cyto evid malign^Papanicolaou smear of vagina with cytologic evidence of malignancy^F^13^742,743,760,761
- +84 ;;795.18^Unsat vaginal cytology smear^Unsatisfactory vaginal cytology smear^F^13^742,743,760,761
- +85 ;;795.19^Oth abn Pap smr vag/vagnal HPV^Other abnormal Papanicolaou smear of vagina and vaginal HPV^F^13^742,743,760,761
- +86 ;;796.70^Abnr glandular Pap smear anus^Abnormal glandular Papanicolaou smear of anus^^6^393,394,395
- +87 ;;796.71^Pap smr anus with ASC-US^Papanicolaou smear of anus with atypical squamous cells of undetermined significance (ASC-US)^^6^393,394,395
- +88 ;;796.72^Pap smr anus w/atypcl sq cells^Papanicolaou smear of anus with atypical squamous cells cannot exclude high grade squamous intraepithelial lesion (ASC-H)^^6^393,394,395
- +89 ;;796.73^Pap smr anus with LGSIL^Papanicolaou smear of anus with low grade squamous intraepithelial lesion (LGSIL)^^6^393,394,395
- +90 ;;796.74^Pap smear anus with HGSIL^Papanicolaou smear of anus with high grade squamous intraepithelial lesion (HGSIL)^^6^393,394,395
- +91 ;;796.75^Anal high rsk HPV DNA test pos^Anal high risk human papillomavirus (HPV) DNA test positive^^6^393,394,395
- +92 ;;796.76^Pap smr anus w/cyto evd malign^Papanicolaou smear of anus with cytologic evidence of malignancy^^6^393,394,395
- +93 ;;796.77^Satsf anal smr lckng trnfor zn^Satisfactory anal smear but lacking transformation zone^^6^393,394,395
- +94 ;;796.78^Unsatsfactry anal cytolgy smr^Unsatisfactory anal cytology smear^^6^393,394,395
- +95 ;;796.79^Oth abno Pap smr anus/anal HPV^Other abnormal Papanicolaou smear of anus and anal HPV^^6^393,394,395
- +96 ;;997.31^Ventilator assoc pneumonia^Ventilator associated pneumonia^^4^205,206
- +97 ;;997.39^Oth respiratory complications^Other respiratory complications^^4^205,206
- +98 ;;998.30^Disruption of wound,unspecif^Disruption of wound, unspecified^^21^919,920,921
- +99 ;;998.33^Disruptn traumatc wound repair^Disruption of traumatic wound repair^^21^919,920,921
- +100 ;;999.81^Extravas of vesicant chemother^Extravasation of vesicant chemotherapy^^5^314,315,316
- +101 ;;999.82^Estravas of Oth vesicant agent^Extravasation of other vesicant agent^^5^314,315,316
- +102 ;;999.88^Other infusion reaction^Other infusion reaction^^5^314,315,316
- +103 ;;999.89^Other transfusion reaction^Other transfusion reaction^^15^791,793
- +104 ;;END
- PRNT ;
- +1 SET U="^"
- +2 WRITE !," CODE",?10,"DIAGNOSIS",!?10,"DESCRIPTION",!," -----",?10,"-----------"
- +3 NEW X,Y,P2,P3
- +4 FOR X=1:1
- SET Y=$PIECE($TEXT(ICD9NEW+X),";;",3)
- SET P2=$PIECE(Y,U,2)
- SET P3=$PIECE(Y,U,3)
- IF Y="END"
- QUIT
- WRITE !," ",$PIECE(Y,U,1),?10,$SELECT($LENGTH(P3):P3,1:P2),!?10,P2
- +5 QUIT